|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
Human influenza hemagglutinin (HA) is a surface glycoprotein required for the infectivity of the human virus. The HA tag is derived from the HA-molecule corresponding to amino acids 98-106 has been extensively used as a general epitope tag in expression vectors. Many recombinant proteins have been engineered to express the HA tag, which does not appear to interfere with the bioactivity or the biodistribution of the recombinant protein. This tag facilitates the detection, isolation, and purification of the proteins.
The actual HA tag is as follows: 5' TAC CCA TAC GAT GTT CCA GAT TAC GCT 3' or 5' TAT CCA TAT GAT GTT CCA GAT TAT GCT 3' The amino acid sequence is: YPYDVPDYA.
|Mouse CDK4 ORF mammalian expression plasmid, C-GFPSpark tag||MG50889-ACG|
|Mouse CDK4 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||MG50889-ACR|
|Mouse CDK4 ORF mammalian expression plasmid, N-GFPSpark tag||MG50889-ANG|
|Mouse CDK4 ORF mammalian expression plasmid, N-OFPSpark / RFP tag||MG50889-ANR|
|Mouse CDK4 ORF mammalian expression plasmid, C-Flag tag||MG50889-CF|
|Mouse CDK4 ORF mammalian expression plasmid, C-His tag||MG50889-CH|
|Mouse CDK4 ORF mammalian expression plasmid, C-Myc tag||MG50889-CM|
|Mouse CDK4 ORF mammalian expression plasmid, C-HA tag||MG50889-CY|
|Mouse CDK4 Gene cDNA clone plasmid||MG50889-G|
|Mouse CDK4 ORF mammalian expression plasmid, N-Flag tag||MG50889-NF|
|Mouse CDK4 ORF mammalian expression plasmid, N-His tag||MG50889-NH|
|Mouse CDK4 ORF mammalian expression plasmid, N-Myc tag||MG50889-NM|
|Mouse CDK4 ORF mammalian expression plasmid, N-HA tag||MG50889-NY|
|Mouse CDK4 natural ORF mammalian expression plasmid||MG50889-UT|
|Learn more about expression Vectors|
CDK4 is a member of the Ser/Thr protein kinase family. It is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of CDK4 is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). CDK4 was shown to be responsible for the phosphorylation of retinoblastoma gene product. CDK4 is the ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. CDK4 has been shown to be mutated in some types of cancer, whilst a chromosomal rearrangement can lead to Cdk6 overexpression in lymphoma, leukemia and melanoma.